Article Search

 Local firm launches new, cheaper Aids drug
    August 06 2003 at 05:03PM Get IOL on your
mobile at m.iol.co.za

A new locally-manufactured, generic anti-Aids drug - up to 41 percent cheaper than the original - was launched in Pretoria on Wednesday.

Manufacturer Aspen Pharmacare said it hoped the drug - Aspen-Stavudine - would eventually form part of a cocktail for Aids patients costing less than $1 (about R7) a day.

It has, to this end, applied to the Medicines Control Council (MCC) to be allowed to also manufacture generics of the drugs Didanosine, Combivir, AZT, 3TC and nevirapine.

Aspen-Stavudine is used to suppress HIV, preventing the immune system from destroying the white blood cells which are required to fight off opportunistic infections.
Continues Below ↓





No orders have been received yet
It is used in combination with other drugs to attack the virus in different stages of its life-cycle - helping the patient to live a healthier life.

The drug was between 17 percent and 41 percent cheaper than its patented version, Zerit, which is produced by Bristol-Myers Squibb.

Different strengths of the drug would cost between R24 and R33,60 for a month's supply, compared to R40,54 for Zerit. This was compared to a monthly cost of about R300 for nevirapine - a similar drug, an official said.

Aspen-Stavudine, the first generic anti-retroviral developed and manufactured in Africa, would be available immediately across the continent. The public and private sectors would be charged the same price.

Aspen Pharmacare chief executive officer Stephen Saad said the company was proud to have developed a home-grown solution to a largely African problem.

'This is the start of a great process'
Of about 44 million HIV and Aids-infected people worldwide, about 75 percent lived in sub-Saharan Africa.

"This (drug) will form one element of a multi-faceted solution to containing the pandemic, the others including inter alia appropriate nutrition, education, prophylaxis and other measures undertaken in government's integrated HIV/Aids strategy."

The company's chief operating officer, Linda Phillip, said no orders have been received yet, but much interest has been shown.


Continues...


Email StoryPrint Story
BOOKMARK THIS STORY
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

muti



     Related Articles
More Health stories

Watch IOLs latest videos on YouTube Join IOLs Facebook page Follow IOL on Twitter





     Online Services

Date Your Destiny
 
I'm a 32 year old man looking to meet women between the ages of 18 and 40.
 

     More Services

     More Health Stories

     Breaking News      Most Read Stories
      Top News Stories
      Top South Africa Stories
      Top Reads - Yesterday



     Entertainment      Motoring
Michael apologises to Lisa Marie
VIDEO: Cars? Check. The Stig? Check. Eye candy? No
Madonna eyes new toyboy

     Business
Cashing in on Mandela, 20 years after freedom
Toyota South Africa recalls 52 546 vehicles
Honda expands airbag recall as more Toyotas probed
FIRST DRIVES: Hyundai's new 'Tucson' and sexy Sonata
Toyota SA in huge accelerator-pedal recall
Struggling new teams can miss three races - Todt
Classic machines howl at Killarney Historic meeting
Yamaha, Ducati set pace at Sepang

     Travel
Travel beats marriage as top Valentine's gift
The Apartment makes diners feel at home
New vision strikes a chord
Discovering the pleasure of paradise
Spend 11 nights cruising the Med
     Careers
Changing lanes in the career highway
Getting to grips with the transport industry
To be your own boss, believe in yourself first
Salary survey puts unstable economy into the equation
Development of child is key